1887
2 - Qatar Thoracic Conference
  • ISSN: 0253-8253
  • EISSN: 2227-0426
Preview this article:

Loading

Article metrics loading...

/content/journals/10.5339/qmj.2024.qitc.19
2024-04-01
2024-07-12
Loading full text...

Full text loading...

/deliver/fulltext/qmj/2024/2/qmj.qitc.19.html?itemId=/content/journals/10.5339/qmj.2024.qitc.19&mimeType=html&fmt=ahah

References

  1. Mathew N, Joel A, Andrews AG, John AO, Singh A. CDK 4/6 inhibitor induced lung injury: A case report and review of literature. Ecancermedicalscience. 2021; 15:1245. https://doi.org/10.3332/ecancer.2021.1245
    [Google Scholar]
  2. Zhang Y, Ma Z, Sun X, Feng X, An Z. Interstitial lung disease in patients treated with cyclin-dependent kinase 4/6 inhibitors: A systematic review and meta-analysis of randomized controlled trials. Breast. 2022; 62:162–169. https://doi.org/10.1016/j.breast.2022.02.011
    [Google Scholar]
/content/journals/10.5339/qmj.2024.qitc.19
Loading
/content/journals/10.5339/qmj.2024.qitc.19
Loading

Data & Media loading...

  • Article Type: Research Article
Keyword(s): Breast cancerdysneanovelPalbociclibPulmonary and Toxicity
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error